International Psoriasis Council
Advancing Knowledge. Improving Care.
The IPC Virtual Psoriasis Masterclass is designed for early career dermatologists who are making treatment decisions and managing patients with psoriasis and are interested in specializing in psoriasis.
Over the five weekly two-hour sessions of the course, IPC’s world-renowned experts will cover various topics, including the pathogenesis of psoriasis, new and emerging therapies, and how to advocate for your patient.
The Masterclass agenda has been carefully developed to provide knowledge for daily use to the practicing dermatologist in an intimate environment designed to maximize faculty/participant interactions. Through lectures, panels, case-based discussions and question-answer sessions, attendees will obtain practical and important information for their clinical practice.
The IPC Masterclass is open to dermatologists who meet the following criteria:
There is no cost to attend the program, but space is limited. The application deadline is January 24, 2024.
Timezones:
Mauritania/ Senegal: 12:00 – 14:00
Algeria/ Morocco/ Nigeria/ Tunisia: 13:00 – 15:00
Egypt/ Libya/ Rwanda/ South Africa: 14:00 – 16:00
Ethiopia/ Iraq/ Kenya/ Tanzania: 15:00 – 17:00
WELCOME + INTRODUCTION
Mahira El Sayed
Pathogenesis: Bench to Bedside
Marwa Amer
Pustular Psoriasis: Classification and Treatment
Siew Eng Choon
Presentations in Skin of Color Including Erythroderma
Mahira El Sayed
Psoriasis as a Systemic Disease
Mahira El Sayed
Audience Q & A
Faculty
CLOSING COMMENTS
Ncoza Dlova
WELCOME + INTRODUCTION
Ncoza Dlova
Global Psoriasis Atlas and SKINCAPE
Christopher Griffiths and Ncoza Dlova
Psoriatic Arthritis for Dermatologists
Anna López Ferrer
Managing Psoriasis in Patients with Infections
Filip Rob
Case Report on HIV & Psoriasis
Case Report on Hepatitis & Psoriasis
Mona El Kalioby
Audience Q & A
Faculty
CLOSING COMMENTS
Nejib Doss
WELCOME + INTRODUCTION
Nejib Doss
Practical Approach to Managing a Psoriasis Patient
Mahira El Sayed, Mohamed El-Komy
How to Treat Patients with Mild Disease
Peter van de Kerkhof
Phototherapy
Mahmoud Abdallah
Conventional Systemics
Mohamed El-Komy
Biologics & Biosimilars
Paolo Gisondi
Audience Q & A
Faculty
CLOSING COMMENTS
Mahira El Sayed
WELCOME + INTRODUCTION
Mahira El Sayed
A Patient with Metabolic Syndrome
Mona El-Kalioby
Usefulness of Alternative Medicine
Priscilla Angwenyi
Psoriasis in Women and Children
Mahira El Sayed
Geriatric Psoriasis
Peter van de Kerkhof
Difficult to Treat Areas
Nejib Doss
Audience Q & A
Faculty
CLOSING COMMENTS
Ncoza Dlova
WELCOME + INTRODUCTION
Ncoza Dlova
Psoriasis in Limited Resource Regions
Fatimata Ly
Challenging cases workshop – delegates
PROGRAM CLOSING
Mahira El Sayed, Ncoza Dlova & Nejib Doss
In this IPC commentary, Matias Maskin examines evidence from the BADBIR registry demonstrating that first-line biologic therapy in moderate to severe psoriasis leads to faster skin clearance, improved quality of life, and a lower risk of comorbidities. The analysis challenges traditional step-up approaches and supports earlier, patient-centered treatment strategies.
What were the key takeaways from the 2026 AAD Annual Meeting? IPC shares updates on diagnostic challenges, psoriasis therapies, and late-breaking research from leading experts.
A new regional collaboration led by IPC and partner organizations aims to improve diagnosis, treatment, and care coordination for psoriasis and psoriatic arthritis across Latin America.
IPC recognizes its 2025 Fellows as IPC Jr. Councilors following the completion of their fellowship. This transition recognizes their contributions to psoriasis research, education, and global collaboration, and marks their expanded role in the IPC network.
The International Psoriasis Council welcomes Mari Løset and Maxwell Sauder as new Councilors, supporting IPC’s global mission in psoriasis research and care.
In this Take Ten with IPC video, Dr. Leandro Leite discusses the most recent advances in psoriasis over the last year (March 2025 – March 2026). Topics include new guidelines, research, and recent studies.
